Clinical Trial Update: Beta-Tricalcium Phosphate and Concentrated Growth Factors in Treatment of Intra-bony Defect Randomized Clinical Trial [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating beta-tricalcium phosphate and concentrated growth factors for intrabony defects in chronic periodontitis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrabony Periodontal Defect
• Periodontitis

Drugs mentioned

• Beta-tricalcium phosphate (beta-tricalcium phosphate)
• Concentrated Growth Factors

Snippet

Sponsor: Tanta University | Conditions: Chronic Periodontitis, Intrabony Periodontal Defect | Phase 2 | Status: COMPLETED